Huang X-H, Liu Z-H. The Clinical Presentation and Management of Systemic Light-Chain Amyloidosis in China. Kidney Dis (Basel). 2016;2(1):1-9.
Ceppi F, Stephens D, Hollander BS den, Krueger J, Whitlock J, Sung L, Hitzler J. Clinical presentation and risk factors of serious infections in children with Down syndrome treated for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2016.
Petruskevicius I, Ludvigsen M, Hjortebjerg R, Sørensen BS, Kamper P, Vase M, Oestgaard LG, Nielsen B, Honoré B, Bjerre M, et al. Clinical relevance of galectin-1 in hematologic malignancies treated with non-myeloablative hemopoietic stem cell transplantation. Bone Marrow Transplant. 2016.
Bao XB, Zhu Q, Qiu HY, Chen F, Xue SL, Ma X, Sun AN, Wu DP. [Clinical risks analysis of EBV infection in patients with allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2016;37(2):138-143.
Harris VK, Vyshkina T, Sadiq SA. Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis. Cytotherapy. 2016.
Marsh JCW, Mufti GJ. Clinical significance of acquired somatic mutations in aplastic anaemia. Int J Hematol. 2016.
Chen X-L, Chen X-Z, Wang Y-G, He D, Lu Z-H, Liu K, Zhang W-H, Wang W, Li C-C, Xue L, et al. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study. Oncotarget. 2016.
Muir KW. Clinical trial design for stem cell therapies in stroke: What have we learned?. Neurochem Int. 2016.
Mohammadi M, Vaezi M, Mirrahimi B, Hadjibabaie M. Clinical use of statins in hematopoietic stem cell transplantation: Old drugs and new horizons. Int J Hematol Oncol Stem Cell Res. 2016;10(1):42-50.
Wang Y, Peng L, Dai Q, Ye L, Chen L, Chen Q, Lai C, Jiang Y, Zhang G. Clinical value to quantitate hematogones in Chinese childhood acute lymphoblastic leukemia by flow cytometry analysis. Int J Lab Hematol. 2016.
Fernandes-Platzgummer A, Carmelo JG, da Silva CLobato, Cabral JMS. Clinical-Grade Manufacturing of Therapeutic Human Mesenchymal Stem/Stromal Cells in Microcarrier-Based Culture Systems. Methods Mol Biol. 2016;1416:375-388.
Borghese C, Agostini F, Durante C, Colombatti A, Mazzucato M, Aldinucci D. Clinical-grade quality platelet-rich plasma releasate (PRP-R/SRGF) from CaCl2 -activated platelet concentrates promoted expansion of mesenchymal stromal cells. Vox Sang. 2016.
Shibahara J, Hayashi A, Misumi K, Sakamoto Y, Arita J, Hasegawa K, Kokudo N, Fukayama M. Clinicopathologic Characteristics of Hepatocellular Carcinoma With Reactive Ductule-like Components, a Subset of Liver Cancer Currently Classified as Combined Hepatocellular-Cholangiocarcinoma With Stem-Cell Features, Typical Subtype. Am J Surg Pathol. 2016.
Bystrykh LV, Belderbos ME. Clonal Analysis of Cells with Cellular Barcoding: When Numbers and Sizes Matter. Methods Mol Biol. 2016.
Colom B, Jones PH. Clonal analysis of stem cells in differentiation and disease. Curr Opin Cell Biol. 2016;43:14-21.
J Wiedmeier E, Kato C, Zhang Z, Lee H, Dunlap J, Nutt E, Rattray R, McKay S, Eide C, Press R, et al. Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women. Exp Hematol. 2016.
Suda Y, Neri S, Hashimoto H, Higuchi Y, Ishibashi M, Sugano M, Masutomi K, Tsuboi M, Ochiai A, Ishii G. Clonal heterogeneity in osteogenic potential of lung cancer-associated fibroblasts: promotional effect of osteogenic progenitor cells on cancer cell migration. J Cancer Res Clin Oncol. 2016.
J Pike W. Closing in on Vitamin D Action in Skeletal Muscle: Early Activity in Muscle Stem Cells?. Endocrinology. 2016;157(1):48-51.
Yu B, Yang Y, Liu H, Gong M, Millard RW, Wang Y-G, Ashraf M, Xu M. Clusterin/Akt Up-Regulation Is Critical for GATA-4 Mediated Cytoprotection of Mesenchymal Stem Cells against Ischemia Injury. PLoS One. 2016;11(3):e0151542.
Guerra B, Martín-Rodríguez P, Díaz-Chico JCarlos, McNaughton-Smith G, Jiménez-Alonso S, Hueso-Falcón I, Montero JCarlos, Blanco R, León J, Rodríguez-González G, et al. CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia. Oncotarget. 2016.
Tarafdar A, Hopcroft LEM, Gallipoli P, Pellicano F, Cassels J, Hair A, Korfi K, Jørgensen HG, Vetrie D, Holyoake TL, et al. CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression. Blood. 2016.
Blyth E, Withers B, Clancy L, Gottlieb D. CMV-specific immune reconstitution following allogeneic stem cell transplantation. Virulence. 2016:1-14.
Su R, Gong J-N, Chen M-T, Song L, Shen C, Zhang X-H, Yin X-L, Ning H-M, Liu B, Wang F, et al. c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia. Oncotarget. 2016.
Muffat J, Li Y, Jaenisch R. CNS disease models with human pluripotent stem cells in the CRISPR age. Curr Opin Cell Biol. 2016;43:96-103.
Greco R, Barbanti MC, Stranghellini MTLupo, Giglio F, Morelli M, Messina C, Forcina A, Oltolini C, Piemontese S, Scarpellini P, et al. Coadministration of posaconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2016.